Biol Reprod Lalor Postdoctoral Fellowships -- Application Deadline January 15, 2009
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow My Folders
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by KLEMCKE, H. G.
Right arrow Articles by BRINKLEY, H. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by KLEMCKE, H. G.
Right arrow Articles by BRINKLEY, H. J.
Agricola
Right arrow Articles by KLEMCKE, H. G.
Right arrow Articles by BRINKLEY, H. J.

Biology of Reproduction, Vol 22, 1029-1039, Copyright © 1980 by Society for the Study of Reproduction

Effects of Bromocriptine and PRL on Luteal and Adrenal Cholesterol Ester Hydrolase and Serum Progesterone Concentrations in Mature Pseudopregnant Rats

HAROLD G. KLEMCKE 1, and HOWARD J. BRINKLEY 1

1 Department of Zoology, University of Maryland, College Park, Maryland 20742


Experiments were conducted to investigate regulation by prolactin (PRL) of luteal, and possibly of adrenal, cholesterol ester hydrolase (CEH) in mature, pseudopregnant rats, and to correlate changes in CEH activity and serum PRL, luteinizing hormone (LH) and progesterone (P) concentrations. 2-Br-agr-ergocryptine (EC), EC plus ovine PRL (oPRL), or EC + P were administered to mature rats on pseudopregnancy Day 5 (PP5) and/or PP6. Injection of EC at 1100 and 2300 h PP5 drastically reduced serum PRL concentrations at 1800 h PP5 and 0600 h PP6, indicating that both the diurnal surge of PRL on PP5 and the nocturnal surge of PRL on PP6 had been successfully blocked. Luteal CEH and serum P measured at these time periods were not affected. However, by 1200 h PP6, both were significantly decreased. Injection of oPRL with EC significantly increased luteal CEH at 0600 h and 1200 h PP6, and significantly increased serum P by 1200 h PP6. However, injection of oPRL at 1600 h PP5 and 0300 h PP6 after EC at 1100 and 2300 h PP5, had no effect on luteal CEH at 0600 h, even though serum P at that time was significantly increased. Blocking only the nocturnal PP6 PRL surge by injection of EC at 2300 h PP5 caused significant reductions in both luteal CEH and serum P by 1200 h PP6, but these decreases were not as great as those observed after elimination of both PRL surges. Injection of oPRL at 0300 h PP6, 4 h after EC (2300 h PP5), significantly increased both luteal CEH and serum P by 1200 h PP6.

Injection of 2 mg P with EC at either 1100 h and 2300 h PP5, or only at 2300 h PP5, had no effect on luteal CEH activity at 1200 h PP6. None of the treatments had any effect on adrenal CEH activity or on serum LH concentrations, except for one treatment (injection of EC plus oPRL at 1100 and 2300 h PP5 followed by sacrifice at 0600 h) which significantly decreased serum LH.

These data indicate that in mature pseudopregnant rats, PRL stimulates luteal CEH activity and concomitantly increases serum P concentrations. A time interval of 6-9 h after exogenous or endogenous PRL is both necessary and optimal for stimulation of luteal CEH. Both PRL surges are necessary for complete luteal function, but the nocturnal surge appears to exert the greater influence on the parameters studied. The action of PRL on luteal CEH does not seem to be mediated by P at concentrations of P injected, and under conditions of these experiments PRL had no effect on adrenal CEH.

Note:
ACKNOWLEDGMENTS The authors gratefully acknowledge NIAMDD for the gift of materials used in the PRL and LH radioimmunoassays, as well as for the ovine PRL used for injections. We also want to thank Sandoz, Inc. for generously supplying the 2-Br-agr-ergocryptine. Finally, we wish to express our appreciation to Dr. Dennis Hoover, University of Maryland School of Medicine, and Dr. Susan Smith, University of Masaachusetts Medical School, for helpful discussions during the conduct of these experiments. We also wish to thank Dr. Andrzej Bartke, University of Texas Health Science Center at San Antonio, for assistance in the preparation of this manuscript, and Ms. Gretta Small for her excellent typing.

Submitted on October 5, 1979
Accepted on February 26, 1980




This article has been cited by other articles:


Home page
Endocr. Rev.Home page
C. Stocco, C. Telleria, and G. Gibori
The Molecular Control of Corpus Luteum Formation, Function, and Regression
Endocr. Rev., February 1, 2007; 28(1): 117 - 149.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1980 by the Society for the Study of Reproduction.